Yes it’s lucky for us we have an excellent management team who...

Yes it’s lucky for us we have an excellent management team who have us in
x3 phase 1 trials
x3 phase 2 trials
and about to start a pivotal study for FDA approval

on a drug that is better than the standard of care in at least one condition GBM!

And soon to read out data on other conditions and with what’s expected to be big news in mid August!!! And based on the scientists involved it could be huge!!

we have money in the bank and an excellent funding strategy that has us noted as ‘a new breed of biotech’! And as we are using cutting edge trial and funding models it’s obvious we earn that mantle.

we have world class oncology research organisations spending their hard earned money and world class oncology scientists excited for this drug and willing to continue with trials at their own costs to make a difference in their various patient cohorts - meaning for around 1 million a month we run our entire company and 6 concurrent trials across hundreds of patients in multiple centres and dozens of doctors/scientists which is an outrageously cheap cost for this much activity at this caliber of scientist

the charts are starting to look ‘incredible’ day on day they are just getting better and better and better...

it’s becoming obvious there is a really big movement afoot here it’s still in a startup, a steady phase and growing day on day but I would expect that at some point, who knows when, but at some point soon we could have some really big movements.

its great to see that after a couple of years of restructuring, pivoting, bringing in a new candidate, rebranding, announcing collaboration after collaboration, etc, etc, that over the last 7 months we have had some remarkable data readouts and we have seen a couple of little pops - green shoots if you like - and when you do your home work you will realise we are not looking at an SP to product value increase of a few tens of percent but literally many factors of the current SP.

if you have been investing and researching various opportunities for a while you will realise there is something very very special going on here - there seems to be multiple elements on a number of levels that are coming into alignment - it’s like watching micro gold miners find a larg deposit at the start of a decade boom in gold.

theres no better place to be on the asx in biotech than Kazia - but if anyone actually has a real other candidate then they should put it forward - pass on the stock code and back up your claim.

its been another great day over here for KZA holders - not so much for those that got out at the bottom a month or so ago and can’t believe their own bad timing!